Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “non-small cell lung cancer”
Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00356122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00406276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
ClinicalTrials.gov study NCT06790303. IPD Sharing: YES. Countries: 3. Publications: 0.
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01438307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01248247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00064350. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), Aft
ClinicalTrials.gov study NCT01853878. IPD Sharing: YES. Countries: 9. Publications: 0.
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05275673. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis
ClinicalTrials.gov study NCT04148898. IPD Sharing: NO. Countries: 0. Publications: 10.
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03713944. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01059643. IPD Sharing: YES. Countries: 1. Publications: 0.
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1
ClinicalTrials.gov study NCT05553808. IPD Sharing: YES. Countries: 12. Publications: 0.
A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab
ClinicalTrials.gov study NCT00508625. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00508144. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04385368. IPD Sharing: YES. Countries: 33. Publications: 0.
A Study of Ramucirumab (IMC-1121B) With Paclitaxel and Carboplatin in Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00735696. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations
ClinicalTrials.gov study NCT01647711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)
ClinicalTrials.gov study NCT03971474. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00266877. IPD Sharing: Not stated. Countries: 5. Publications: 0.
LMB-100 Followed by Pembrolizumab in the Treatment of Adults With Mesothelin-Expressing Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT04027946. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.